carbamazepine has been researched along with Coronary Artery Disease in 4 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We present a case of serotonin syndrome, which was precipitated by this medicine in a patient who had been predisposed by long-term treatment with sertraline, a selective serotonin reuptake inhibitor." | 7.78 | Fatal serotonin syndrome precipitated by oxcarbazepine in a patient using an selective serotonin reuptake inhibitor. ( Dardis, C; Ly, V; Omoregie, E, 2012) |
| "Epileptic patients receiving medications such as phenytoin or phenobarbital have been noted to have an exceedingly low incidence of myocardial infarction, but children treated with carbamazepine have shown alteration of their serum lipid profile that could predispose them to atherosclerosis." | 7.72 | Epilepsy, atherosclerosis, myocardial infarction, and carbamazepine. ( de Chadarévian, JP; Katsetos, CD; Legido, A; Miles, DK, 2003) |
| " Using propensity score matching, two of four network-based predictions are validated in patient-level data: carbamazepine is associated with an increased risk of coronary artery disease (CAD) [hazard ratio (HR) 1." | 3.88 | Network-based approach to prediction and population-based validation of in silico drug repurposing. ( Barabási, AL; Cheng, F; Desai, RJ; Handy, DE; Loscalzo, J; Schneeweiss, S; Wang, R, 2018) |
| " We present a case of serotonin syndrome, which was precipitated by this medicine in a patient who had been predisposed by long-term treatment with sertraline, a selective serotonin reuptake inhibitor." | 3.78 | Fatal serotonin syndrome precipitated by oxcarbazepine in a patient using an selective serotonin reuptake inhibitor. ( Dardis, C; Ly, V; Omoregie, E, 2012) |
| "Epileptic patients receiving medications such as phenytoin or phenobarbital have been noted to have an exceedingly low incidence of myocardial infarction, but children treated with carbamazepine have shown alteration of their serum lipid profile that could predispose them to atherosclerosis." | 3.72 | Epilepsy, atherosclerosis, myocardial infarction, and carbamazepine. ( de Chadarévian, JP; Katsetos, CD; Legido, A; Miles, DK, 2003) |
| "Treatment with carbamazepine (CBZ) is known to affect apolipoprotein B-containing lipoprotein concentrations in serum." | 1.32 | Lipoprotein(a) concentration increases during treatment with carbamazepine. ( Berthold, HK; Brämswig, S; Luers, C; Sudhop, T; von Bergmann, K, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, F | 1 |
| Desai, RJ | 1 |
| Handy, DE | 1 |
| Wang, R | 1 |
| Schneeweiss, S | 1 |
| Barabási, AL | 1 |
| Loscalzo, J | 1 |
| Dardis, C | 1 |
| Omoregie, E | 1 |
| Ly, V | 1 |
| Brämswig, S | 1 |
| Sudhop, T | 1 |
| Luers, C | 1 |
| von Bergmann, K | 1 |
| Berthold, HK | 1 |
| de Chadarévian, JP | 1 |
| Legido, A | 1 |
| Miles, DK | 1 |
| Katsetos, CD | 1 |
4 other studies available for carbamazepine and Coronary Artery Disease
| Article | Year |
|---|---|
Network-based approach to prediction and population-based validation of in silico drug repurposing.
Topics: Carbamazepine; Computer Simulation; Coronary Artery Disease; Databases, Factual; Drug Repositioning; | 2018 |
Fatal serotonin syndrome precipitated by oxcarbazepine in a patient using an selective serotonin reuptake inhibitor.
Topics: Aged, 80 and over; Analgesics; Antihypertensive Agents; Atrial Fibrillation; Bronchodilator Agents; | 2012 |
Lipoprotein(a) concentration increases during treatment with carbamazepine.
Topics: Adult; Anticonvulsants; Carbamazepine; Cholesterol; Cholesterol, LDL; Coronary Artery Disease; Diabe | 2003 |
Epilepsy, atherosclerosis, myocardial infarction, and carbamazepine.
Topics: Anticonvulsants; Autopsy; Carbamazepine; Child; Coronary Artery Disease; Epilepsy; Fatal Outcome; Hu | 2003 |